Skip to main content
Earnings Labs
Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated (PRLD) Earnings

NASDAQ·Healthcare·Biotechnology

$4.20

-13.40%

Mkt Cap $261.32M

EPS — Estimate vs Actual

Mkt Cap

$261.32M

P/E

Fwd P/E

P/S

20.15

Rev TTM

EPS TTM

-$1.58